Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCSH pseudogene 6 is a non-coding pseudogene related to the *GCSH* gene, which encodes the glycine cleavage system H protein, a mitochondrial component involved in glycine degradation[3][5][11]. GCSHP6 itself does not encode a protein and is not a known therapeutic target. Pseudogenes like GCSHP6 are often considered genomic "fossils" of protein-coding genes and may be transcribed at low levels or serve as regulatory elements (for example, producing long non-coding RNAs), but for GCSHP6 specifically, there is no clear evidence of functional RNA products, disease association, or therapeutic relevance[1][4][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine cleavage system H protein pseudogene 6 (GCSHP6).